Previous close | 59.00 |
Open | 58.30 |
Bid | 57.50 |
Ask | 59.90 |
Strike | 70.00 |
Expiry date | 2024-09-20 |
Day's range | 58.30 - 59.00 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Eli Lilly stock broke out after the company reported positive results for Crohn's disease drug. Is LLY stock a buy right now?
(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have gotten a nod from analysts at Goldman Sachs Group Inc.Most Read from BloombergWorld’s Largest Nuclear Plant Sits Idle While Energy Needs Soar‘Not Gonna Be Pretty:’ Covid-Era Homebuyers Face Huge Rate JumpWarning Signals Are Flashing for Homeowners in Texas and FloridaInsurers Sink as UnitedHealth Sees ‘Disturbance’ in MedicaidAmerican Air Fired Commercial Head After Sales Strategy Alienated Corporate